观察研究
荟萃分析
不宁腿综合征
癫痫
医学
精神科
儿科
心理学
物理医学与康复
内科学
神经学
作者
Ahmed M. Talaia,Ahmed Saad Ahmed El-Nahhas,Nourhan M. Talaia,Abdelaziz Abdelaal
标识
DOI:10.1016/j.sleep.2024.05.004
摘要
Epilepsy is a common neurological disorder that significantly contributes to the worldwide disease burden. Restless legs syndrome is sleep-related movement disorder that causes uncomfortable sensations in the legs with an irresistible urge to move them. The aim of this study is to comprehensively assess the current evidence to estimate the prevalence of restless legs syndrome (RLS) in adults with epilepsy (AWE) and to compare it to healthy controls. PubMed, Medline, Scopus, and Web of Science databases were searched for observational studies reporting the prevalence of RLS in AWE. The modified Newcastle-Ottawa Scale (NOS) was used to evaluate the quality of the studies. Comprehensive Meta-Analysis software (version 3.0) was used to perform data analysis. The heterogeneity of the studies was assessed using the I2 index. The pooled prevalence of RLS in AWE and the odds ratio were calculated based on the random-effect model. Sensitivity analysis was assessed. A funnel plot and Egger's test were used to investigate publication bias. Subgroup analysis and univariate meta-regression analysis were done. Based on the analysis of 17 studies (2262 AWE patients), the prevalence of RLS was 14.9% (95%CI, 10.4%–21%). This rate was highest in the Americas (35.3%; 95% CI: 19.7-54.9%) and lowest in Asian countries (11.6%). The risk of RLS was significantly higher in AWE patients compared to health controls (12 studies, OR=2.09; 95% CI: 1.53-2.85, I2=91.69%, P<0.001). subgroup analysis showed Variations in RLS rates between studies depending on quality scores, methodology, and diagnostic criteria. The funnel plot and Egger's test suggest there was publication bias. Sensitivity analysis showed that none of the studies on their own significantly affected the results. This meta-analysis provides the first pooled estimate of RLS prevalence in AWE. RLS occurs in 15 out of every 100 AWE patients, and the risk is high compared to healthy controls. However, the findings need to be confirmed in future studies owing to limitations in the analysis and study design.
科研通智能强力驱动
Strongly Powered by AbleSci AI